Rapport Therapeutics (NASDAQ:RAPP - Get Free Report)'s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $12.69, but opened at $13.51. Rapport Therapeutics shares last traded at $13.76, with a volume of 11,234 shares changing hands.
Rapport Therapeutics Price Performance
The business's fifty day moving average is $20.26 and its two-hundred day moving average is $21.42.
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of RAPP. ARCH Venture Management LLC purchased a new position in Rapport Therapeutics in the 2nd quarter worth about $86,730,000. Sofinnova Investments Inc. bought a new stake in shares of Rapport Therapeutics in the second quarter worth approximately $45,393,000. Perceptive Advisors LLC bought a new position in Rapport Therapeutics during the second quarter valued at approximately $17,403,000. FMR LLC lifted its position in Rapport Therapeutics by 10.1% during the third quarter. FMR LLC now owns 5,486,468 shares of the company's stock valued at $112,363,000 after purchasing an additional 503,117 shares during the period. Finally, Logos Global Management LP purchased a new stake in Rapport Therapeutics in the second quarter worth approximately $4,859,000.
Rapport Therapeutics Company Profile
(
Get Free Report)
Rapport Therapeutics Inc is a clinical-stage biotechnology company. It focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. Rapport Therapeutics Inc is based in BOSTON.
See Also
Before you consider Rapport Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rapport Therapeutics wasn't on the list.
While Rapport Therapeutics currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
